$MQ

Cummings Martha sold $12K of MQ

Cummings Martha sold 713 shares of Marqeta, Inc. (MQ) at $16.22 on 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cummings Martha
Published Jul 16, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 16, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MQ
Neutral
medium confidence
Mentioned
$MQ
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MQNeutralLow
01

Why it matters

Insider sales under 10b5-1 plans are often mechanically scheduled and may not reflect new information; traders typically treat this as low-signal unless paired with other negative disclosures.

02

Market read

A director’s scheduled sale is disclosed, but the text contains no new operational, financial, or regulatory catalyst for Marqeta.

03

What to watch

The sale size is relatively small and the plan is pre-arranged, which reduces interpretability as a fresh negative signal.

Relevance 2/10Novelty 3/10Timing: Filed 2026-07-16 after-hours, reflecting an insider sale dated 2026-07-15.

Background

The article is an SEC Form 4 insider transaction disclosure for Marqeta, Inc., reported by a director.

Company-level read

Ticker impact

$MQNeutralMedium confidence
Context

Marqeta director Martha Cummings sold 713 shares on 2026-07-15 at $16.2200/share under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal, unless investors interpret the sale as a broader confidence signal.

Evidence & confidence

The filing is a Form 4 insider transaction, but the article provides no new company-specific operational or financial development beyond the sale details.

Market effects

No clear sector read-through from a single director 10b5-1 sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with investor skepticism and may modestly pressure sentiment.

Key entities

  • Marqeta, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Martha Cummings

    Director who sold 713 shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$INTUMedAI 8/10

Finance and HR Software Stocks Q2 Recap: Benchmarking Marqeta (NASDAQ:MQ)

Intuit (INTU) reported $4.35B revenue (up 13.7% YoY), beating expectations, but lowered full-year guidance, causing its stock to fall 10.1%. BILL (BILL) reported $436.2M revenue (up 13.8% YoY), beating expectations, but missed full-year revenue guidance. Paychex (PAYX) reported $1.61B revenue (up 12.5% YoY), meeting expectations, and its stock rose 18.2%.

$INTUMed

Q2 Earnings Highs And Lows: Intuit (NASDAQ:INTU) Vs The Rest Of The Finance and HR Software Stocks

Intuit (INTU) reported Q2 revenue of $4.35B, up 13.7% YoY, but missed EPS guidance, causing shares to drop 12.5%. American Express Global Business Travel (GBTG) saw 37.9% revenue growth, beating estimates. Marqeta (MQ) reported $176M revenue, up 17% YoY, but missed guidance. Paylocity (PCTY) beat estimates with 11% growth. BlackLine (BL) reported $187.8M revenue, in line with expectations but down 13.2% post-earnings.

$MQMed

Marqeta, Inc. (MQ): Results of Operations and Financial Condition

Marqeta, Inc. (MQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. MARQETA REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS The global modern card issuer reported Total Processing Volume growth of 32% and Gross Profit growth of 17% in the second quarter of 2026. OAKLAND, Calif. – August 4, 2026 - Marqeta, Inc. (NASDAQ: MQ) , the global modern card

$MQMed

10 Stocks That Have the Potential to Rise 1000%

The article compiles 10 stocks it says could deliver 10x gains, citing views from Baillie Gifford, Fidelity, and Franklin Templeton about asymmetric upside and growth potential. It outlines selection criteria based on frequent appearance across financial lists and recent catalysts. Example picks include Marqeta (Q1 revenue $165.8M vs $164.2M consensus; Europe expansion) and Jumia (Q1 revenue $50.6M; targeting adjusted EBITDA breakeven in Q4 2026).